An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical ...

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...

TORONTO, March 09, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...

Detailed price information for Profound Medical Corp (PRN-T) from The Globe and Mail including charting and trades.

Early trials of the drug VIR-5500 showed it shrinking tumours in some patients A new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.

In a new study, researchers found microplastics deep inside prostate cancer tumors, raising more questions about the role the ubiquitous pollutants play in public health. The findings — which come ...